According to researchers, “While consumers are experiencing more cost sharing that in fact shifts more of the drug cost burden on to them, on balance in the US consumers have experienced substantial price declines.”

A new study finds that generic drugs are a good deal for consumers; even given the cost-shifting that comes with some health plans, generic prices have gone down steadily in recent years. However, the move to high-deductible health plans means that consumers have seen fewer overall savings than they might have.

The study by the National Bureau of Economic Research (NBER), assisted by a grant from the National Institutes of Health, looked at prices for generic drugs between 2007 and 2016. The researchers noted that media accounts have reported sharp increases in specific generic drugs. A 2018 study by USC found an increase in cases of price increases for some generic drugs—but even that study found increases in less than 5 percent of all generic drugs.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.